Your browser doesn't support javascript.
loading
A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers.
Reiss, Kim A; Herman, Joseph M; Armstrong, Deborah; Zahurak, Marianna; Fyles, Anthony; Brade, Anthony; Milosevic, Michael; Dawson, Laura A; Scardina, Angela; Fischer, Patricia; Hacker-Prietz, Amy; Kinders, Robert J; Wang, Lihua; Chen, Alice; Temkin, Sarah; Horiba, Naomi; Stayner, Lee-Anne; Siu, Lillian L; Azad, Nilofer S.
Afiliação
  • Reiss KA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Department of Medical Oncology, United States.
  • Herman JM; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Department of Radiation Oncology, United States.
  • Armstrong D; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Department of Medical Oncology, United States.
  • Zahurak M; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Department of Statistics, United States.
  • Fyles A; Princess Margaret Cancer Centre/University Health Network, Department of Radiation Oncology, University of Toronto, Canada.
  • Brade A; Princess Margaret Cancer Centre/University Health Network, Department of Radiation Oncology, University of Toronto, Canada.
  • Milosevic M; Princess Margaret Cancer Centre/University Health Network, Department of Radiation Oncology, University of Toronto, Canada.
  • Dawson LA; Princess Margaret Cancer Centre/University Health Network, Department of Radiation Oncology, University of Toronto, Canada.
  • Scardina A; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Department of Medical Oncology, United States.
  • Fischer P; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Department of Medical Oncology, United States.
  • Hacker-Prietz A; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Department of Radiation Oncology, United States.
  • Kinders RJ; National Cancer Institute, Office of the Director, United States.
  • Wang L; National Cancer Institute, Office of the Director, United States.
  • Chen A; National Cancer Institute, Cancer Therapy Evaluation Program, United States.
  • Temkin S; The University of Maryland School of Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, United States.
  • Horiba N; The University of Maryland School of Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, United States.
  • Stayner LA; Princess Margaret Cancer Centre/University Health Network, Department of Medical Oncology and Hematology, University of Toronto, Canada.
  • Siu LL; Princess Margaret Cancer Centre/University Health Network, Department of Medical Oncology and Hematology, University of Toronto, Canada.
  • Azad NS; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Department of Medical Oncology, United States. Electronic address: nazad2@jhmi.edu.
Gynecol Oncol ; 144(3): 486-490, 2017 03.
Article em En | MEDLINE | ID: mdl-28109627
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Benzimidazóis / Neoplasias das Tubas Uterinas / Inibidores de Poli(ADP-Ribose) Polimerases Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Benzimidazóis / Neoplasias das Tubas Uterinas / Inibidores de Poli(ADP-Ribose) Polimerases Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos